Alto Net Receivables from 2010 to 2026
| ANRO Stock | 16.71 0.13 0.77% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 7.2 K | Current Value 6.8 K | Quarterly Volatility 819.9 K |
Check Alto Neuroscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alto Neuroscience's main balance sheet or income statement drivers, such as Net Interest Income of 9 M, Interest Income of 10.7 M or Selling General Administrative of 26.1 M, as well as many indicators such as Price To Sales Ratio of 2 K, Dividend Yield of 0.0 or PTB Ratio of 0.65. Alto financial statements analysis is a perfect complement when working with Alto Neuroscience Valuation or Volatility modules.
Alto | Net Receivables | Build AI portfolio with Alto Stock |
Evaluating Alto Neuroscience's Net Receivables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Alto Neuroscience's fundamental strength.
Latest Alto Neuroscience's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Alto Neuroscience over the last few years. It is Alto Neuroscience's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alto Neuroscience's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Alto Net Receivables Regression Statistics
| Arithmetic Mean | 1,162,179 | |
| Geometric Mean | 329,035 | |
| Coefficient Of Variation | 70.55 | |
| Mean Deviation | 751,651 | |
| Median | 1,743,000 | |
| Standard Deviation | 819,898 | |
| Sample Variance | 672.2B | |
| Range | 1.7M | |
| R-Value | (0.84) | |
| Mean Square Error | 210.9B | |
| R-Squared | 0.71 | |
| Significance | 0.000024 | |
| Slope | (136,411) | |
| Total Sum of Squares | 10.8T |
Alto Net Receivables History
About Alto Neuroscience Financial Statements
Alto Neuroscience investors utilize fundamental indicators, such as Net Receivables, to predict how Alto Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 7.2 K | 6.8 K |
Pair Trading with Alto Neuroscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alto Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience will appreciate offsetting losses from the drop in the long position's value.Moving against Alto Stock
| 0.72 | PSGTF | PT Semen Indonesia | PairCorr |
| 0.48 | HPQ | HP Inc | PairCorr |
| 0.41 | MMM | 3M Company | PairCorr |
| 0.32 | IBM | International Business | PairCorr |
The ability to find closely correlated positions to Alto Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alto Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alto Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alto Neuroscience to buy it.
The correlation of Alto Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alto Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Alto Neuroscience Correlation against competitors. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Pharmaceuticals sector continue expanding? Could Alto diversify its offerings? Factors like these will boost the valuation of Alto Neuroscience. If investors know Alto will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alto Neuroscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Alto Neuroscience requires distinguishing between market price and book value, where the latter reflects Alto's accounting equity. The concept of intrinsic value - what Alto Neuroscience's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alto Neuroscience's price substantially above or below its fundamental value.
Understanding that Alto Neuroscience's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alto Neuroscience represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alto Neuroscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.